Concepedia

Li‐Fan Zeng

LZ

31

Publications

1.5K

Citations

24

H-Index

1995

Active since

Affiliations

Indiana University School of Medicine(Current)

Indiana University – Purdue University Indianapolis

University of California San Diego

Shanghai Institute of Materia Medica

Chinese Academy of Sciences

Li‐Fan Zeng is an author at Indiana University School of Medicine specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryCell BiologyNatural SciencesCell SignalingChemical BiologyMedicinal ChemistrySignal Transduction

Publications per year

1995–2022

31

Publications

31

Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis

Severa Bunda, Kelly Burrell, Pardeep Heir et al. · Nature Communications · 2015 · 228 citations · Full text

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase

Li‐Fan Zeng, Ruo-Yu Zhang, Zhi-Hong Yu et al. · Journal of Medicinal Chemistry · 2014 · 131 citations · Full text

Chemoprevention Strategy, Shp2 Active Site, Cancer Biology +22

Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts.

Edward J. Goetzl, Songzhu An, Li‐Fan Zeng · The Journal of Immunology · 1995 · 88 citations

Prostaglandin E2, Signal Transduction, Apoptosis +13

Targeting Inactive Enzyme Conformation: Aryl Diketoacid Derivatives as a New Class of PTP1B Inhibitors

Sijiu Liu, Li‐Fan Zeng, Wu Li et al. · Journal of the American Chemical Society · 2008 · 83 citations · Full text

Drug Target, Molecular Biology, Chemical Biology +16

Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus

Jianxun Wang, Masayuki Mizui, Li‐Fan Zeng et al. · Journal of Clinical Investigation · 2016 · 68 citations · Full text

Rows per page

1–5 of 31